Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | PRKDC | P78527 | 6/20 | 0.37 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.37 |
| ▸ | F9 | P00740 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17307480 | 0.95 | ALOX5 (0.50) | ALOX5PRKDCPARP14F9MAPT | |
| SCHEMBL17307465 | 0.94 | ALOX5 (0.53) | ALOX5PRKDCPARP14F9MAPT | |
| SCHEMBL17307454 | 0.91 | ALOX5 (0.38) | ALOX5PRKDCPARP14F9MAPT | |
| SCHEMBL17307463 | 0.87 | ALOX5 (0.40) | ALOX5PRKDCPARP14MAPT | |
| SCHEMBL17307469 | 0.87 | ALOX5 (0.39) | ALOX5PRKDCPARP14MAPT | |
| SCHEMBL17307477 | 0.87 | ALOX5 (0.40) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL17307481 | 0.87 | ALOX5 (0.40) | ALOX5PRKDCPIK3CDBRD4PIK3CA | |
| SCHEMBL17307425 | 0.86 | ALOX5 (0.36) | ALOX5PRKDCF9MAPT | |
| SCHEMBL17307438 | 0.85 | ALOX5 (0.38) | ALOX5PRKDCPARP14F9MAPT | |
| SCHEMBL17932230 | 0.85 | ALOX5 (0.37) | ALOX5PARP14F9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9653690-B2 | Organic compound, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2017-05-16 | — | — | US | disclosed |
| US-9653690-B2 | Organic compound, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2017-05-16 | — | — | US | disclosed |
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OXER1, OR10J3 | ALOX5 798/4885PRKDC 2184/4885PARP14 4827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.